Mediastinal germ cell tumors: clinical aspects and outcomes in 7 children

A De Backer1, G C Madern, F G A J Hakvoort-Cammel

  • 1Section of Pediatric Surgery, Academic Hospital, Free University of Brussels, Laarbeeklaan 101, 1090 Brussels, Belgium. antoine.debacker@az.vub.ac.be

Insights

Mediastinal germ cell tumors are rare in children. Benign tumors treated with surgery have excellent outcomes, while malignant tumors benefit from chemotherapy, improving survival rates.

Area of Science:

  • Pediatric Oncology
  • Thoracic Surgery
  • Tumor Biology

Background:

  • Mediastinal germ cell tumors (MGCTs) are exceptionally rare in pediatric populations.
  • Limited literature exists on the clinical presentation and management of childhood MGCTs.

Purpose of the Study:

  • To report on the clinical presentations, treatment modalities, complications, and outcomes of children diagnosed with mediastinal germ cell tumors.
  • To analyze the prognostic factors and treatment effectiveness for pediatric MGCTs.

Main Methods:

  • Retrospective chart review of 7 pediatric patients treated for MGCT between 1971 and 2001.
  • Analysis of patient demographics, symptoms, surgical procedures, histological findings, chemotherapy regimens, and patient outcomes.

Main Results:

  • Four patients with benign mature teratomas achieved complete remission after surgical excision, with no recurrences observed.
  • Three patients with malignant tumors (yolk sac tumor, choriocarcinoma, malignant teratoma) received chemotherapy, with one survivor in remission.
  • Common presenting symptoms included respiratory distress, persistent cough, chest pain, and weight loss.

Conclusions:

  • Childhood MGCTs are rare and often present with severe symptoms.
  • Complete surgical excision offers an excellent prognosis for benign mediastinal germ cell tumors.
  • Platinum-based chemotherapy has significantly improved survival rates for malignant mediastinal germ cell tumors in children.
Abstract

Related Concept Videos